Dupont Capital Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,003
Closed -$158K 935
2022
Q4
$158K Sell
2,003
-4,511
-69% -$363K 0.01% 837
2022
Q3
$482K Sell
6,514
-3,111
-32% -$223K 0.03% 654
2022
Q2
$627K Buy
9,625
+4,591
+91% +$272K 0.03% 626
2022
Q1
$318K Sell
5,034
-446
-8% -$24.3K 0.01% 908
2021
Q4
$291K Sell
5,480
-6,738
-55% -$411K 0.01% 978
2021
Q3
$862K Sell
12,218
-1,717
-12% -$108K 0.03% 649
2021
Q2
$929K Buy
13,935
+10,276
+281% +$727K 0.02% 668
2021
Q1
$406K Buy
3,659
+2,235
+157% +$277K 0.01% 1032
2020
Q4
$169K Buy
1,424
+1,093
+330% +$118K ﹤0.01% 1162
2020
Q3
$29K Sell
331
-21,993
-99% -$1.92M ﹤0.01% 1230
2020
Q2
$2M Sell
22,324
-3,085
-12% -$312K 0.04% 314
2020
Q1
$2.53M Sell
25,409
-14,128
-36% -$1.53M 0.06% 235
2019
Q4
$4.54M Buy
39,537
+6,267
+19% +$758K 0.1% 166
2019
Q3
$4.2M Buy
33,270
+9,720
+41% +$1.23M 0.1% 182
2019
Q2
$2.83M Sell
23,550
-2,175
-8% -$214K 0.06% 288
2019
Q1
$2.25M Buy
25,725
+2,925
+13% +$266K 0.05% 339
2018
Q4
$2.28M Sell
22,800
-3,482
-13% -$366K 0.06% 321
2018
Q3
$3.01M Sell
26,282
-14,071
-35% -$1.46M 0.07% 282
2018
Q2
$3.62M Buy
40,353
+22,535
+126% +$1.9M 0.09% 212
2018
Q1
$1.3M Sell
17,818
-7,639
-30% -$524K 0.03% 441
2017
Q4
$1.48M Buy
+25,457
New +$1.34M 0.03% 430

Other funds holding HAE

Dupont Capital Management's HAE Position: Q1 2023 in Review

Dupont Capital Management sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 2,003 shares — an estimated $158K sold.

Dupont Capital Management first reported a position in HAE in Q4 2017 and held it in 21 quarters. The position peaked at $4.54M in Q4 2019. 301 funds tracked by Wall St. Rank hold HAE as of Q1 2023.

  • Dupont Capital Management reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 2,003 Haemonetics shares in Q1 2023, an estimated $158K.
  • Dupont Capital Management first reported a position in Haemonetics in Q4 2017 and held it in 21 quarters.
  • Dupont Capital Management's Haemonetics position peaked at $4.54M in Q4 2019.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.